• Organization TypeService Providers
  • HeadquartersUnited Kingdom
  • Founded2008

QuantuMDx Group Ltd

About QuantuMDx Group is a multinational life science, tools and diagnostics company with a global vision: to revolutionise molecular diagnostics and help eradicate disease by making accurate diagnostics universally accessible. We have invented the Q-POC™, a DNA analyser which compresses a molecular diagnostics laboratory into a simple-to-use, portable, affordable device. For just a few pounds per test, it can be used anywhere from remote rural settings to clinics and hospitals, providing results within 10 - 30 minutes, depending on the complexity of the test. With its high-quality testing for diseases such as TB, HPV and STIs, the battery-operated device aims to bring the power of precision medicine to health professionals globally, enabling patients to be tested, diagnosed and given treatment options in one efficient consultation. Our aim is for geotagged pathogen data from each connected Q-POC™ to facilitate global disease surveillance and mapping, promoting a joined-up approach to disease control and eradication. Our technologies also have potential utility across many markets including sample preparation, concentration of pathogens from large and complex samples (CAPTURE-XT™) and the detection of DNA from humans and pathogens (Q-POC™). Headquartered in the UK, QuantuMDx has operations and global partnerships with healthcare providers in the United States, Asia, Europe and Africa – keeping it at the forefront of molecular diagnostics.
See more


Contract Awards

Design and Execution of COVID-19 Testing Kits

Department for International Development (DFID) - United Kingdom

Company Offices

  • United Kingdom (headquarters)
  • Lugano Bldg, 57 Melbourne St, Newcastle upon Tyne NE1 2JQ, United Kingdom